TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.3 MARKET SHARE ESTIMATION 22
2.3.1 KEY DATA FROM SECONDARY SOURCES 22
2.3.2 KEY DATA FROM PRIMARY SOURCES 22
2.3.3 ASSUMPTIONS 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 29
4.1 GLOBAL NERVE REPAIR AND REGENERATION MARKET OVERVIEW 29
4.2 LIFE CYCLE ANALYSIS, BY REGION 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 33
5.2 MARKET SEGMENTATION 33
5.2.1 BY PRODUCT 33
5.2.2 BY APPLICATION 34
5.3 MARKET DYNAMICS 34
5.3.1 DRIVERS 36
5.3.1.1 Large numbers of nerve injuries and increasing incidences of neurological disorders 36
5.3.1.2 Rapidly aging population worldwide 36
5.3.1.3 Technological advancements in nerve repair to aid market growth 37
5.3.1.4 Favorable reimbursement policies 37
5.3.1.5 Expanded target applications and new indications are expected to increase the demand for neuromodulation devices. 38
5.3.2 RESTRAINTS 39
5.3.2.1 Lack of patient awareness 39
5.3.2.2 Dearth of professionals, including trained surgeons 39
5.3.3 OPPORTUNITIES 39
5.3.3.1 Novel therapies such as stem cell therapy 39
5.3.3.2 Emerging markets 40
5.3.4 CHALLENGES 41
5.3.4.1 Donor site morbidity 41
5.3.4.2 Inadequate nerve regeneration by conduits 41
5.3.4.3 Stringent regulatory frameworks and time-consuming approval processes 41
6 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT 43
6.1 INTRODUCTION 44
6.2 NEUROSTIMULATION AND NEUROMODULATION DEVICES 46
6.2.1 INTERNAL NEUROSTIMULATION DEVICES 48
6.2.1.1 Spinal cord stimulation 49
6.2.1.2 Deep brain stimulation 50
6.2.1.3 Vagus nerve stimulation 51
6.2.1.4 Sacral nerve stimulation 52
6.2.1.5 Gastric electrical stimulation 53
6.2.2 EXTERNAL NEUROSTIMULATION DEVICES 54
6.2.2.1 Transcutaneous electrical nerve stimulation 55
6.2.2.2 Transcranial magnetic stimulation 56
6.3 BIOMATERIALS 57
6.3.1 NERVE CONDUITS 58
6.3.2 NERVE PROTECTORS 59
6.3.3 NERVE WRAPS 60
6.3.4 NERVE CONNECTORS 60
7 NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION 61
7.1 INTRODUCTION 62
7.2 NEUROSTIMULATION AND NEUROMODULATION SURGERIES 64
7.2.1 INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES 66
7.2.2 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES 66
7.3 DIRECT NERVE REPAIR/NEURORRHAPHY 67
7.3.1 EPINEURAL REPAIR 69
7.3.2 PERINEURAL REPAIR 69
7.3.3 GROUP FASCICULAR REPAIR 70
7.4 NERVE GRAFTING 71
7.4.1 AUTOGRAFT 72
7.4.2 ALLOGRAFT 73
7.4.3 XENOGRAFT 74
7.5 STEM CELL THERAPY 75
8 NERVE REPAIR AND REGENERATION MARKET, BY REGION 76
8.1 INTRODUCTION 77
8.2 NORTH AMERICA 79
8.3 EUROPE 86
8.4 ASIA 91
8.5 REST OF THE WORLD 98
9 COMPETITIVE LANDSCAPE 103
9.1 INTRODUCTION 103
9.2 STRATEGIC OVERVIEW 103
9.3 LEADING PLAYERS IN THE NERVE REPAIR AND REGENERATION MARKET 105
9.4 COMPETITIVE SITUATION AND TRENDS 107
9.4.1 NEW PRODUCT LAUNCHES 107
9.4.2 ACQUISITIONS AND MERGERS 108
9.4.3 EXPANSION 109
9.4.4 AGREEMENTS 110
10 COMPANY PROFILES 111
(Overview, Financials, Products & Services, Strategy, & Developments)*
10.1 INTRODUCTION 111
10.2 AXOGEN, INC. 112
10.3 BAXTER INTERNATIONAL INC. 114
10.4 BOSTON SCIENTIFIC CORPORATION 116
10.5 CYBERONICS, INC. 119
10.6 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 122
10.7 MEDTRONIC, PLC. 125
10.8 ST. JUDE MEDICAL, INC. 129
10.9 STRYKER CORPORATION 132
10.10 ORTHOMED S.A.S. 134
10.11 POLYGANICS B.V. 135
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
11 APPENDIX 136
11.1 INSIGHTS OF INDUSTRY EXPERTS 136
11.2 DISCUSSION GUIDE 137
11.3 OTHER DEVELOPMENTS (JANUARY 2012–JUNE 2015) 139
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 141
11.5 AVAILABLE CUSTOMIZATIONS 142
11.6 RELATED REPORTS 143
LIST OF TABLES
TABLE 1 NERVE REPAIR AND REGENERATION MARKET SUMMARY 24
TABLE 2 INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES AND NEUROLOGICAL DISORDERS ARE PROPELLING THE GROWTH OF THE NERVE REPAIR AND REGENERATION MARKET 38
TABLE 3 LACK OF TRAINED PROFESSIONALS TO NEGATIVELY IMPACT THE GROWTH OF THE NERVE REPAIR AND REGENERATION MARKET 39
TABLE 4 INCREASING USE OF STEM CELL THERAPY IS PAVING NEW GROWTH AVENUES FOR PLAYERS IN THE NERVE REPAIR AND REGENERATION MARKET 41
TABLE 5 STRINGENT REGULATORY FRAMEWORKS ARE A MAJOR CHALLENGE FOR PLAYERS IN THE NERVE REPAIR AND REGENERATION MARKET 42
TABLE 6 NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 45
TABLE 7 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 46
TABLE 8 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET SIZE,
BY REGION, 2013–2020 (USD MILLION) 47
TABLE 9 INTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 48
TABLE 10 INTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 48
TABLE 11 SPINAL CORD STIMULATION MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 49
TABLE 12 DEEP BRAIN STIMULATION MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 50
TABLE 13 VAGUS NERVE STIMULATION MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 51
TABLE 14 SACRAL NERVE STIMULATION MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 52
TABLE 15 GASTRIC ELECTRICAL STIMULATION MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 53
TABLE 16 EXTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 54
TABLE 17 EXTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 54
TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE,
BY REGION, 2013–2020 (USD MILLION) 55
TABLE 19 TRANSCRANIAL MAGNETIC STIMULATION MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 56
TABLE 20 BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 57
TABLE 21 BIOMATERIALS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 58
TABLE 22 NERVE CONDUITS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 59
TABLE 23 NERVE PROTECTOR MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 59
TABLE 24 NERVE WRAPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 60
TABLE 25 NERVE CONNECTOR MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 60
TABLE 26 NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION,
2013–2020 (USD MILLION) 63
TABLE 27 NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE,
BY APPLICATION, 2013–2020 (USD MILLION) 64
TABLE 28 NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE,
BY REGION, 2013–2020 (USD MILLION) 65
TABLE 29 INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 66
TABLE 30 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 66
TABLE 31 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET SIZE, BY APPLICATION,
2013–2020 (USD MILLION) 67
TABLE 32 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 68
TABLE 33 EPINEURAL REPAIR MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 69
TABLE 34 PERINEURAL REPAIR MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 69
TABLE 35 GROUP FASCICULAR REPAIR MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 70
TABLE 36 NERVE GRAFTING MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 71
TABLE 37 NERVE GRAFTING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 72
TABLE 38 AUTOGRAFT MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 73
TABLE 39 ALLOGRAFT MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 73
TABLE 40 XENOGRAFT MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 74
TABLE 41 STEM CELL THERAPY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 75
TABLE 42 NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 78
TABLE 43 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 81
TABLE 44 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 82
TABLE 45 NORTH AMERICA: INTERNAL NEUROSTIMULATION MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 83
TABLE 46 NORTH AMERICA: EXTERNAL NEUROMODULATION MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 83
TABLE 47 NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 84
TABLE 48 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SIZE,
BY APPLICATION, 2013–2020 (USD MILLION) 85
TABLE 49 EUROPE: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 87
TABLE 50 EUROPE: NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 87
TABLE 51 EUROPE: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 88
TABLE 52 EUROPE: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 88
TABLE 53 EUROPE: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 89
TABLE 54 EUROPE: NERVE REPAIR AND REGENERATION MARKET SIZE,
BY APPLICATION, 2013–2020 (USD MILLION) 90
TABLE 55 ASIA: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 93
TABLE 56 ASIA: NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 94
TABLE 57 ASIA: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 94
TABLE 58 ASIA: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 95
TABLE 59 ASIA: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 96
TABLE 60 ASIA: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION,
2013–2020 (USD MILLION) 97
TABLE 61 ROW: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 99
TABLE 62 ROW: NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 99
TABLE 63 ROW: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 100
TABLE 64 ROW: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION) 100
TABLE 65 ROW: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 101
TABLE 66 ROW: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION,
2013–2020 (USD MILLION) 102
TABLE 67 MARKET DEVELOPMENTS BETWEEN 2012 AND 2015 107
TABLE 68 NEW PRODUCT LAUNCHES, 2012–2015 107
TABLE 69 ACQUISITIONS AND MERGERS, 2012–2015 108
TABLE 70 EXPANSIONS, 2012–2015 109
TABLE 71 AGREEMENTS, 2012–2015 110
FIGURE 1 GLOBAL NERVE REPAIR AND REGENERATION MARKET 15
FIGURE 2 RESEARCH DESIGN 17
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 19
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 20
FIGURE 6 DATA TRIANGULATION METHODOLOGY 21
FIGURE 7 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015 VS. 2020 25
FIGURE 8 BIOMATERIALS MARKET, BY PRODUCT, 2015 VS. 2020 25
FIGURE 9 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY PRODUCT, 2015 VS. 2020 26
FIGURE 10 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET,
BY PRODUCT, 2015 VS. 2020 26
FIGURE 11 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET,
BY PRODUCT, 2015 VS. 2020 27
FIGURE 12 NERVE REPAIR AND REGENERATION MARKET, BY REGION, 2015 VS. 2020 27
FIGURE 13 INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES & NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH 29
FIGURE 14 NEUROSTIMULATION & NEUROMODULATION SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 30
FIGURE 15 ASIA TO WITNESS FASTEST GROWTH RATE IN THE FORECAST PERIOD
(2015 TO 2020) 30
FIGURE 16 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES 31
FIGURE 17 NERVE REPAIR AND REGENERATION MARKET SEGMENTATION: BY PRODUCT 33
FIGURE 18 NERVE REPAIR AND REGENERATION MARKET SEGMENTATION: BY APPLICATION 34
FIGURE 19 INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES AND NEUROLOGICAL DISORDERS WILL DRIVE THE NERVE REPAIR AND REGENERATION MARKET IN THE FORECAST PERIOD 35
FIGURE 20 GROWING AGING POPULATION IS AN IMPORTANT DRIVER FOR THE NERVE REPAIR AND REGENERATION MARKET 37
FIGURE 21 GROWTH IN HEALTHCARE EXPENDITURE IN ASIA AND ROW OUTPACING THAT OF NORTH AMERICA AND EUROPE 40
FIGURE 22 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT 44
FIGURE 23 NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2015 (USD MILLION) 45
FIGURE 24 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES TO DOMINATE MARKET IN 2015 46
FIGURE 25 NORTH AMERICA EXPECTED TO HOLD LARGEST SHARE OF THE NEUROSTIMULATION AND NEUROMODULATION DEVICES SEGMENT 47
FIGURE 26 NERVE CONDUITS ACCOUNT FOR THE LARGEST SHARE OF THE BIOMATERIALS SEGMENT IN 2015 57
FIGURE 27 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE BIOMATERIALS MARKET DURING THE FORECAST PERIOD 58
FIGURE 28 NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION 62
FIGURE 29 NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION,
2015 (USD MILLION) 63
FIGURE 30 INTERNAL SURGERIES ACCOUNT FOR THE LARGEST SHARE OF THE NEUROSTIMULATION AND NEUROMODULATION APPLICATION SEGMENT 64
FIGURE 31 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE NEUROSTIMULATION AND NEUROMODULATION SURGERIES SEGMENT IN 2015 65
FIGURE 32 EPINEURAL REPAIR ACCOUNTS FOR THE LARGEST SHARE OF THE DIRECT NERVE REPAIR/NEURORRHAPHY SEGMENT IN 2015 67
FIGURE 33 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE DIRECT NERVE REPAIR/NEURORRHAPHY SEGMENT IN 2015 68
FIGURE 34 AUTOGRAFTS ACCOUNT FOR THE LARGEST SHARE OF THE NERVE GRAFTING SEGMENT IN 2015 71
FIGURE 35 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE NERVE GRAFTING SEGMENT IN 2015 72
FIGURE 36 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE STEM CELL THERAPY SEGMENT IN 2015 75
FIGURE 37 NERVE REPAIR AND REGENERATION MARKET SEGMENTATION, BY REGION 77
FIGURE 38 NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION
(MARKET SIZE AND GROWTH RATE) 77
FIGURE 39 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT 80
FIGURE 40 NEUROSTIMULATION AND NEUROMODULATION DEVICES TO DOMINATE THE NERVE REPAIR AND REGENERATION MARKET IN NORTH AMERICA 81
FIGURE 41 INTERNAL NEUROSTIMULATION TO FORM THE LARGEST SEGMENT OF THE MARKET IN NORTH AMERICA IN 2015 82
FIGURE 42 NERVE CONDUITS TO FORM THE LARGEST SEGMENT OF THE BIOMATERIALS MARKET IN NORTH AMERICA 84
FIGURE 43 NEUROSTIMULATION AND NEUROMODULATION SURGERY TO BE THE LARGEST APPLICATION SEGMENT OF THE MARKET IN NORTH AMERICA (2015) 85
FIGURE 44 NEUROSTIMULATION AND NEUROMODULATION DEVICES DOMINATED THE MARKET IN EUROPE (2015) 86
FIGURE 45 INTERNAL NEUROSTIMULATION TO FORM THE LARGEST SEGMENT OF THE NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET IN EUROPE (2015) 87
FIGURE 46 NERVE CONDUITS TO FORM THE LARGEST SEGMENT OF THE BIOMATERIALS MARKET IN EUROPE (2015) 89
FIGURE 47 NEUROSTIMULATION AND NEUROMODULATION SURGERY ESTIMATED TO BE THE LARGEST APPLICATION SEGMENT OF THE MARKET IN EUROPE 90
FIGURE 48 ASIA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT 92
FIGURE 49 NEUROSTIMULATION AND NEUROMODULATION DEVICES TO DOMINATE THE MARKET IN ASIA (2015) 93
FIGURE 50 INTERNAL NEUROSTIMULATION TO FORM THE LARGEST SEGMENT OF THE NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET IN ASIA 94
FIGURE 51 NERVE CONDUITS TO COMMAND THE LARGEST SHARE OF THE BIOMATERIALS MARKET IN ASIA 95
FIGURE 52 NEUROSTIMULATION AND NEUROMODULATION SURGERY TO BE THE LARGEST APPLICATION SEGMENT OF THE MARKET IN ASIA (2015) 96
FIGURE 53 NEUROSTIMULATION AND NEUROMODULATION DEVICES DOMINATED THE ROW MARKET IN 2015 98
FIGURE 54 INTERNAL NEUROSTIMULATION TO DOMINATE THE NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET IN THE ROW 99
FIGURE 55 NERVE CONDUITS ESTIMATED TO COMMAND THE LARGEST SHARE OF THE BIOMATERIALS MARKET IN THE ROW 101
FIGURE 56 NEUROSTIMULATION AND NEUROMODULATION SURGERY TO BE THE LARGEST APPLICATION SEGMENT OF THE ROW MARKET (2015) 102
FIGURE 57 KEY DEVELOPMENTS IN THE NERVE REPAIR AND REGENERATION MARKET,
2012-2015 104
FIGURE 58 NERVE REPAIR AND REGENERATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 105
FIGURE 59 SNAPSHOT OF FINANCIAL PERFORMANCE OF LEADING MARKET PLAYERS 111
FIGURE 60 AXOGEN, INC.: COMPANY SNAPSHOT 112
FIGURE 61 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT 114
FIGURE 62 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 116
FIGURE 63 CYBERONICS, INC.: COMPANY SNAPSHOT 119
FIGURE 64 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT 122
FIGURE 65 MEDTRONIC, PLC.: COMPANY SNAPSHOT 125
FIGURE 66 ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT 129
FIGURE 67 STRYKER CORPORATION: COMPANY SNAPSHOT 132